CARM1 inhibitors (Bristol-Myers Squibb/Nerviano)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameCARM1 inhibitors (Bristol-Myers Squibb/Nerviano)
Drug Alias Namecoactivator-associated arginine methyltransferase 1 inhibitors (Bristol-Myers Squibb/Nerviano)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone-arginine methyltransferase CARM1 inhibitors
TargetsHistone-arginine methyltransferase CARM1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNerviano Medical Sciences SrlBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A